Skip to main content
Johnson & Johnson8-K: Restructuring

Johnson & Johnson acquires Firefly Bio and partners with Sail Biomedicines, impacting 2026 EPS by $0.64.

What happened

The acquisition and strategic collaboration will reduce 2026 adjusted pre-tax operating margin by approximately 150 basis points and EPS by $0.64, indicating significant investment and integration costs.

Source

SEC EDGARJul 29, 2026

Current report (Form 8-K)

Johnson & Johnson 8-K

Filing excerpt

On July 29, 2026, Johnson & Johnson (the “Company”) announced the completion of the acquisition of Firefly Bio, Inc. (“Firefly”) and the entry into strategic agreements and collaboration with Sail Biomedicines (“Sail”).

sec.gov/Archives/edgar/data/200406/000020040626000163/jnj-20260729.htmRead the full source

Other signals in this filing (2)

Extracted by Autobound

From the Signal API record
Signal
8-K: Restructuring

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Fiscal year end
07/29
Filed
Jul 29, 2026

The full record

From the Signal API record

Numbers

PercentDecrease in adjusted pre-tax operating margin vs. prior guidance.
1.5%

Details

CIK
200406
Accession number
0000200406-26-000163
Timeframe
Immediate
Filing year
2026
Why it matters
Change management needs
Signal category
Workforce

Topics and mentions

Vendors

  • Firefly Bio
  • Inc.
  • Sail Biomedicines

Vendors named

  • Firefly Bio, Inc.
  • Sail Biomedicines

Extraction

Confidence
High
Relevance
90%
Sentiment
Neutral
Detected
Aug 4, 2026
signal_type
sec-8k
signal_subtype
restructuring

Use this data

Get every 8-K signal for Johnson & Johnson and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Johnson & Johnson this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/4f61e3fe-371f-4d43-bbbb-f868d56777fd returns this record as JSON. POST /v1/companies/enrich returns every signal for jnj.com.

{
  "signal_id": "4f61e3fe-371f-4d43-bbbb-f868d56777fd",
  "signal_type": "sec-8k",
  "signal_subtype": "restructuring",
  "detected_at": "2026-08-04T07:04:14.265+00:00",
  "company": {
    "name": "Johnson & Johnson",
    "domain": "jnj.com"
  },
  "data": {
    "detail": "The acquisition and strategic collaboration will reduce 2026 adjusted pre-tax operating margin by approximately 150 basis points and EPS by $0.64, indicating significant investment and integration costs. This major strategic shift creates opportunities for vendors specializing in post-merger integration, system consolidation, and operational efficiency.",
    "metrics": {
      "pct": 1.5,
      "timeframe": "immediate",
      "pct_context": "Decrease in adjusted pre-tax operating margin vs. prior guidance.",
      "dollar_context": "The filing reports a $0.64 decrease in earnings per share, not a total dollar amount."
    },
    "summary": "Johnson & Johnson acquires Firefly Bio and partners with Sail Biomedicines, impacting 2026 EPS by $0.64.",
    "excerpts": "On July 29, 2026, Johnson & Johnson (the “Company”) announced the completion of the acquisition of Firefly Bio, Inc. (“Firefly”) and the entry into strategic agreements and collaboration with Sail Biomedicines (“Sail”).",
    "relevance": 0.9,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000020040626000163/jnj-20260729.htm",
    "filing_date": "2026-07-29",
    "filing_year": 2026,
    "fiscal_year_end": "07/29",
    "sales_relevance": "Change management needs",
    "signal_category": "workforce",
    "vendors_mentioned": [
      "Firefly Bio, Inc.",
      "Sail Biomedicines"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.